Procter & Gamble CO Form 4 insider transactions

Procter & Gamble's CEO of Beauty, R. Alexandra Keith, reported significant acquisitions of common stock, restricted stock units, and preferred stock through various company compensation plans.

Procter & Gamble's CEO of Baby, Fem & Family Care, Ma. Fatima Francisco, received a retirement award of 1,260 Restricted Stock Units.

Procter & Gamble's CEO of Health Care, Jennifer L. Davis, reported an increase in her beneficial ownership of company stock through recent restricted stock unit grants and retirement plan adjustments.

Procter & Gamble's SVP and Chief Accounting Officer, Matthew W. Janzaruk, reported changes in his beneficial ownership of company stock, including RSU grants and adjustments to retirement plan holdings.

Procter & Gamble CEO Jon R. Moeller reported increased beneficial ownership of common stock, restricted stock units, and preferred stock through recent compensation-related grants.

Procter & Gamble's CEO of Grooming, Gary A. Coombe, received grants of Restricted Stock Units as part of dividend equivalents and a retirement award.

Procter & Gamble Director Ashley McEvoy was awarded 185 shares of common stock as part of the company's 2019 Stock and Incentive Compensation Plan, increasing her beneficial ownership to 3,636.1013 shares.

Procter & Gamble Co. Director Joseph Jimenez was awarded 292 Restricted Stock Units as part of the company's 2019 Stock and Incentive Compensation Plan, increasing his beneficial ownership to over 33,658 shares.

Procter & Gamble Director Patricia A. Woertz has reported the acquisition of 185 Restricted Stock Units (RSUs) on June 10, 2025, as part of the company's 2019 Stock and Incentive Compensation Plan.

Procter & Gamble Co. Director Robert Portman was granted 47 Restricted Stock Units as part of the company's 2019 Stock and Incentive Compensation Plan, increasing his beneficial ownership to 3,348.7485 shares.

Procter & Gamble Director Christine M. McCarthy has increased her beneficial ownership of company common stock by 231 shares through an award of Restricted Stock Units.

Procter & Gamble Co. Director Terry J. Lundgren reported the acquisition of 223 Restricted Stock Units (RSUs) as part of the company's compensation plan, increasing his direct beneficial ownership.

Procter & Gamble Co. Director Christopher J. Kempczinski acquired 185 shares of common stock on June 10, 2025, through a Restricted Stock Unit award under the company's 2019 Stock and Incentive Compensation Plan.

Procter & Gamble Director Craig Arnold has reported the acquisition of 511 shares of common stock through Restricted Stock Units under the company's 2019 Stock and Incentive Compensation Plan.

Moses Victor Javier Aguilar, a Chief Research, Development & Innovation Officer at Procter & Gamble, reported the acquisition and disposal of company stock and derivative securities on May 5, 2025.

Jennifer L. Davis, CEO Health Care at Procter & Gamble, reported the sale of 1,000 shares of common stock and the acquisition of restricted stock units (RSUs).

Director Robert Portman reports acquisition of Procter & Gamble common stock in a recent SEC filing.

Director Patricia A. Woertz reports acquisition of Procter & Gamble common stock and restricted stock units.

Director Joseph Jimenez reports acquiring 246 shares of Procter & Gamble common stock through restricted stock units.

Director Christopher Kempczinski reports acquiring 145 shares of Procter & Gamble common stock through restricted stock units and dividend equivalents.

Director Terry J. Lundgren reports acquiring 181 shares of Procter & Gamble common stock and holding 42,400.5418 shares directly and 530 shares indirectly through a spouse.

Director Christine M. McCarthy reports acquiring 188 shares of Procter & Gamble common stock on March 11, 2025, through restricted stock units and dividend equivalents.

Director Ashley McEvoy reports acquiring 145 shares of Procter & Gamble common stock on March 11, 2025, through the company's 2019 Stock and Incentive Compensation Plan.

Gary A. Coombe, CEO Grooming at Procter & Gamble, exercised stock options and sold shares on February 28, 2025.

Gary A. Coombe, CEO Grooming at Procter & Gamble, reported the sale of 18,000 shares of common stock and acquisition of restricted stock units.

Matthew W. Janzaruk, SVP Chief Accounting Officer of Procter & Gamble, reports the disposal of common stock held indirectly through a retirement plan trustee.

Chief Brand Officer Marc S. Pritchard reports exercising stock options and selling shares of Procter & Gamble common stock on January 23, 2025.

Chief Research, Development & Innovation Officer at Procter & Gamble, Moses Victor Javier Aguilar, reports multiple transactions involving company stock and restricted stock units.

A Procter & Gamble executive, Fatima Francisco, reported the acquisition and disposal of company stock and restricted stock units.

Marc S. Pritchard, Chief Brand Officer at Procter & Gamble, reported transactions involving company stock and restricted stock units.